Vortioxetine Film-Coated Tablets Suppliers & Bulk Manufacturers
Available Forms: Film-Coated Tablets
Available Strengths: 5 mg, 10 mg, 15 mg(EU only), 20 mg
Reference Brands: Trintellix®(US); Brintellix®(EU)
Category: Antipsychotropic Drugs
Vortioxetine is a serotonin modulator and stimulator that inhibits serotonin reuptake and acts on multiple 5-HT receptors. It is approved for treating major depressive disorder (MDD) in adults, improving both mood and cognitive symptoms. Vortioxetine offers favourable tolerability with minimal sexual side effects and weight gain compared to other antidepressants. Vortioxetine Film-Coated Tablets is available in Film-Coated Tablets and strengths such as 5 mg, 10 mg, 15 mg(EU only), 20 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Vortioxetine Film-Coated Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Vortioxetine Film-Coated Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Vortioxetine film-coated tablets are FDA-approved in the United States for the treatment of major depressive disorder (MDD) in adults. As a serotonin modulator and stimulator, vortioxetine's approval includes strict labeling for suicidal thoughts and behaviors, particularly in young adults. Regulatory requirements in the U.S. include GMP-compliant manufacturing, bioequivalence standards for generics, and ongoing post-marketing surveillance. In the European Union, vortioxetine is authorized under the centralized EMA procedure for the treatment of MDD. EU regulations require a comprehensive Risk Management Plan (RMP), safety monitoring, and periodic safety update reports (PSURs). For dossier-ready sourcing and global supply options, visit Pharmatradz.com.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Bupropion Hydrobromide
Strength:
75 mg, 100 mg, 150mg, 300 mg
Form: Tablets
Reference Brands: Wellbutrin (USA), Zyban (USA)
View DetailsAmitriptyline Hydrochloride
Strength:
10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg
Form: Tablets
Reference Brands: Elavil (USA), Vanatrip (USA), Saroten (EU)
View DetailsOlanzapine + Fluoxetine Hydrochloride
Strength:
6 mg + 25 mg , 3mg+25mg
Form: Capsules
Reference Brands: Symbyax (USA)
View DetailsNefazodone Hydrochloride
Strength:
50 mg, 100 mg, 150 mg, 200 mg,250 mg
Form: Tablets
Reference Brands: Serzone (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers